Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture

Sci Rep. 2020 Jun 10;10(1):9393. doi: 10.1038/s41598-020-66229-w.

Abstract

Three-dimensional (3D) organoid culture holds great promises in cancer precision medicine. However, Matrigel and stem cell-stimulating supplements are necessary for culturing 3D organoid cells. It costs a lot of money and consumes more time and effort compared with 2D cultured cells. Therefore, the establishment of cheaper and Matrigel-free organoid culture that can maintain the characteristics of a part of 3D organoids is demanded. In the previous study, we established a dog bladder cancer (BC) 3D organoid culture system by using their urine samples. Here, we successfully isolated cells named "2.5D organoid" from multiple strains of dog BC 3D organoids using 2.5 organoid media. The cell proliferation speed of 2.5D organoids was faster than parental 3D organoid cells. The expression pattern of stem cell markers was close to 3D organoids. Injection of 2.5D organoid cells into immunodeficient mice formed tumors and showed the histopathological characteristics of urothelial carcinoma similar to the injection of dog BC 3D organoids. The 2.5D organoids had a similar sensitivity profile for anti-cancer drug treatment to their parental 3D organoids. These data suggest that our established 2.5D organoid culture method might become a reasonable and useful tool instead of 3D organoids in dog BC research and therapy.

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Biomarkers, Tumor / metabolism
  • Cell Culture Techniques / methods
  • Cell Proliferation / drug effects
  • Cell Proliferation / physiology
  • Dogs
  • Drug Screening Assays, Antitumor / methods
  • Male
  • Mice
  • Organoids / drug effects
  • Organoids / metabolism
  • Organoids / pathology*
  • Stem Cells / drug effects
  • Stem Cells / metabolism
  • Stem Cells / pathology
  • Tumor Cells, Cultured
  • Urinary Bladder Neoplasms / drug therapy
  • Urinary Bladder Neoplasms / pathology*

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor